igf 1 lr3 review LONG® R³ IGF-I Recombinant Human LR3 IGF-I/IGF-1 GMP
Description
Stimulation with lipopolysaccharide (LPS) and IFN not only activated M0 macrophages into M1 phenotype but also upregulated the expression of inducible nitric oxide synthase (iNOS) in Gpx4-deficient macrophages
If you notice diminishing effects after 8-10 weeks of daily use, taking 2-3 days off can help reset response
Soltani et al
doi: 10.22038/IJBMS.2019.36821.8774
